Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
复制标题
DOI:
10.1182/blood.2020009871
复制
发表时间:
2021-10-21
期刊:
影响因子:
20.3
通讯作者:
Swaminathan S
中科院分区:
文献类型:
--
作者:
Duault C;Kumar A;Taghi Khani A;Lee SJ;Yang L;Huang M;Hurtz C;Manning B;Ghoda L;McDonald T;Lacayo NJ;Sakamoto KM;Carroll M;Tasian SK;Marcucci G;Yu J;Caligiuri MA;Maecker HT;Swaminathan S
Duault and colleagues investigated samples from 20 patients with B- or T-cell acute lymphoblastic leukemia (ALL) and identified defective maturation of natural killer (NK) effector cells and accumulation of less cytotoxic hyperactivated cytokine-producing NK cells. Increased frequency of activated cytokine-producing NK cells is an independent predictor of poor clinical outcome in ALL. These findings suggest that NK cell profiling may have prognostic potential in this setting. Defective maturation of NK effector cells leads to accumulation of less cytotoxic hyperactivated cytokine-producing NK cells in patients with B/T-ALL. Increased frequency of activated cytokine-producing NK cells independently predicts poor clinical outcome in patients with ALL. B- and T-cell acute lymphoblastic leukemia (B/T-ALL) may be refractory or recur after therapy by suppressing host anticancer immune surveillance mediated specifically by natural killer (NK) cells. We delineated the phenotypic and functional defects in NK cells from high-risk patients with B/T-ALL using mass cytometry, flow cytometry, and in silico cytometry, with the goal of further elucidating the role of NK cells in sustaining acute lymphoblastic leukemia (ALL) regression. We found that, compared with their normal counterparts, NK cells from patients with B/T-ALL are less cytotoxic but exhibit an activated signature that is characterized by high CD56, high CD69, production of activated NK cell–origin cytokines, and calcium (Ca2+) signaling. We demonstrated that defective maturation of NK cells into cytotoxic effectors prevents NK cells from ALL from lysing NK cell–sensitive targets as efficiently as do normal NK cells. Additionally, we showed that NK cells in ALL are exhausted, which is likely caused by their chronic activation. We found that increased frequencies of activated cytokine-producing NK cells are associated with increased disease severity and independently predict poor clinical outcome in patients with ALL. Our studies highlight the benefits of developing NK cell profiling as a diagnostic tool to predict clinical outcome in patients with ALL and underscore the clinical potential of allogeneic NK cell infusions to prevent ALL recurrence.
登录
查看更多内容
影响因子:
2.8
作者:
Geller MA;Miller JS
通讯作者:
Miller JS
影响因子:
16.8
作者:
Curran EK;Godfrey J;Kline J
通讯作者:
Kline J
DOI:
10.1126/science.1198704
发表时间:
2011-05-06
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Bendall SC;Simonds EF;Qiu P;Amir el-AD;Krutzik PO;Finck R;Bruggner RV;Melamed R;Trejo A;Ornatsky OI;Balderas RS;Plevritis SK;Sachs K;Pe'er D;Tanner SD;Nolan GP
通讯作者:
Nolan GP
影响因子:
17.1
作者:
Brentjens RJ;Davila ML;Riviere I;Park J;Wang X;Cowell LG;Bartido S;Stefanski J;Taylor C;Olszewska M;Borquez-Ojeda O;Qu J;Wasielewska T;He Q;Bernal Y;Rijo IV;Hedvat C;Kobos R;Curran K;Steinherz P;Jurcic J;Rosenblat T;Maslak P;Frattini M;Sadelain M
通讯作者:
Sadelain M
影响因子:
20.3
作者:
Gardner, Rebecca;Wu, David;Turtle, Cameron J.
通讯作者:
Turtle, Cameron J.